Publication | Closed Access

Evaluation of the efficacy and safety of β-d-mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial

RheumatologySpondyloarthritisβ-D-mannuronic Acid12-Week RandomizedInflammatory Rheumatic DiseaseMedicineOrthopaedic SurgeryAxial Spondyloarthritis